Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum
CN105899241A
Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection.
EP3006453A1
17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors
US2015010629A1
Controlled release and taste masking oral pharmaceutical composition
US2014127292A1
Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
ITMI20131924A1
EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC AND MUCOSAL RESECTIONING AND / OR
US2013209559A1
Method for treating intestinal diseases presenting at least one inflammatory component
EP2722058A1
Solid oral composition containing dyes for use in endoscopic diagnosis
BRPI1105676A2
Method for treating inflammatory bowel disease (ibd) or irritable bowel syndrome (ibs), and, oral pharmaceutical composition
AU2011248587A1
Controlled release and taste masking oral pharmaceutical composition
EP2629778A1
Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome
WO2012013495A1
Pharmaceutical and/or dietary compositions based on short chain fatty acids
ITMI20100345A1
SOLID COMPOSITION FOR ORAL ADMINISTRATION OF DYES, AND DIAGNOSTIC USE OF THE SAME
AU2008243202A1
Oral antimicrobial pharmaceutical compositions
CN101534800A
Pharmaceutical compositions for the oral or rectal administration of protein substances
EP2081555A2
Pharmaceutical compositions for the oral or rectal administration of protein substances
